These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

541 related items for PubMed ID: 10487612

  • 21. Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) in esophageal squamous cell carcinoma.
    Kato H, Yoshikawa M, Miyazaki T, Nakajima M, Fukai Y, Masuda N, Fukuchi M, Manda R, Tsukada K, Kuwano H.
    Anticancer Res; 2002; 22(6C):3977-84. PubMed ID: 12553021
    [Abstract] [Full Text] [Related]

  • 22. Gene expression of vascular endothelial growth factor and its receptors and angiogenesis in bronchial asthma.
    Hoshino M, Nakamura Y, Hamid QA.
    J Allergy Clin Immunol; 2001 Jun; 107(6):1034-8. PubMed ID: 11398081
    [Abstract] [Full Text] [Related]

  • 23. Vascular endothelial growth factor isoforms display distinct activities in promoting tumor angiogenesis at different anatomic sites.
    Guo P, Xu L, Pan S, Brekken RA, Yang ST, Whitaker GB, Nagane M, Thorpe PE, Rosenbaum JS, Su Huang HJ, Cavenee WK, Cheng SY.
    Cancer Res; 2001 Dec 01; 61(23):8569-77. PubMed ID: 11731444
    [Abstract] [Full Text] [Related]

  • 24. Expression of vascular endothelial growth factor (VEGF) and VEGF receptor-1 (Flt-1) in Graves disease possibly correlated with increased vascular density.
    Nagura S, Katoh R, Miyagi E, Shibuya M, Kawaoi A.
    Hum Pathol; 2001 Jan 01; 32(1):10-7. PubMed ID: 11172289
    [Abstract] [Full Text] [Related]

  • 25. KDR/Flk-1 is a major regulator of vascular endothelial growth factor-induced tumor development and angiogenesis in murine hepatocellular carcinoma cells.
    Yoshiji H, Kuriyama S, Hicklin DJ, Huber J, Yoshii J, Miyamoto Y, Kawata M, Ikenaka Y, Nakatani T, Tsujinoue H, Fukui H.
    Hepatology; 1999 Nov 01; 30(5):1179-86. PubMed ID: 10534339
    [Abstract] [Full Text] [Related]

  • 26. The angiogenic pathway "vascular endothelial growth factor/flk-1(KDR)-receptor" in rheumatoid arthritis and osteoarthritis.
    Giatromanolaki A, Sivridis E, Athanassou N, Zois E, Thorpe PE, Brekken RA, Gatter KC, Harris AL, Koukourakis IM, Koukourakis MI.
    J Pathol; 2001 May 01; 194(1):101-8. PubMed ID: 11329148
    [Abstract] [Full Text] [Related]

  • 27. [Expression of vascular endothelial growth factor and its receptor (Flt-1) in breast carcinoma].
    Wu H, Li Y, Zhu G, Zhang L, Zhang X, He X.
    Zhonghua Yi Xue Za Zhi; 2002 May 25; 82(10):708-11. PubMed ID: 12133473
    [Abstract] [Full Text] [Related]

  • 28. Expression of vascular endothelial growth factor (VEGF) and its receptors is regulated in eyes with intra-ocular tumours.
    Stitt AW, Simpson DA, Boocock C, Gardiner TA, Murphy GM, Archer DB.
    J Pathol; 1998 Nov 25; 186(3):306-12. PubMed ID: 10211121
    [Abstract] [Full Text] [Related]

  • 29. Expression of vascular endothelial growth factor (VEGF) and its two receptors (VEGF-R1-Flt1 and VEGF-R2-Flk1/KDR) in non-small cell lung carcinomas (NSCLCs): correlation with angiogenesis and survival.
    Decaussin M, Sartelet H, Robert C, Moro D, Claraz C, Brambilla C, Brambilla E.
    J Pathol; 1999 Aug 25; 188(4):369-77. PubMed ID: 10440746
    [Abstract] [Full Text] [Related]

  • 30. Developmental expression of vascular endothelial growth factor (VEGF) receptors and VEGF binding in ovine placenta and fetal membranes.
    Bogic LV, Brace RA, Cheung CY.
    Placenta; 2001 Apr 25; 22(4):265-75. PubMed ID: 11286562
    [Abstract] [Full Text] [Related]

  • 31. A potential autocrine role for vascular endothelial growth factor in prostate cancer.
    Jackson MW, Roberts JS, Heckford SE, Ricciardelli C, Stahl J, Choong C, Horsfall DJ, Tilley WD.
    Cancer Res; 2002 Feb 01; 62(3):854-9. PubMed ID: 11830543
    [Abstract] [Full Text] [Related]

  • 32. Lymphatic versus blood vascular endothelial growth factors and receptors in humans.
    Partanen TA, Paavonen K.
    Microsc Res Tech; 2001 Oct 15; 55(2):108-21. PubMed ID: 11596156
    [Abstract] [Full Text] [Related]

  • 33. Expression of the VEGF-receptor Flt-1 in benign, premalignant and malignant prostate tissues.
    Hahn D, Simak R, Steiner GE, Handisurya A, Susani M, Marberger M.
    J Urol; 2000 Aug 15; 164(2):506-10. PubMed ID: 10893635
    [Abstract] [Full Text] [Related]

  • 34. [Expression of vascular endothelial growth factor and its receptors, flt-1 and kinase insert domain-containing receptor in normal human endometrium during menstrual cycle].
    Wang H, Chen G.
    Zhonghua Fu Chan Ke Za Zhi; 2002 Dec 15; 37(12):729-32. PubMed ID: 12622916
    [Abstract] [Full Text] [Related]

  • 35. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation.
    Yano S, Herbst RS, Shinohara H, Knighton B, Bucana CD, Killion JJ, Wood J, Fidler IJ.
    Clin Cancer Res; 2000 Mar 15; 6(3):957-65. PubMed ID: 10741721
    [Abstract] [Full Text] [Related]

  • 36. PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration.
    Wood JM, Bold G, Buchdunger E, Cozens R, Ferrari S, Frei J, Hofmann F, Mestan J, Mett H, O'Reilly T, Persohn E, Rösel J, Schnell C, Stover D, Theuer A, Towbin H, Wenger F, Woods-Cook K, Menrad A, Siemeister G, Schirner M, Thierauch KH, Schneider MR, Drevs J, Martiny-Baron G, Totzke F.
    Cancer Res; 2000 Apr 15; 60(8):2178-89. PubMed ID: 10786682
    [Abstract] [Full Text] [Related]

  • 37. Highly metastatic human prostate cancer growing within the prostate of athymic mice overexpresses vascular endothelial growth factor.
    Balbay MD, Pettaway CA, Kuniyasu H, Inoue K, Ramirez E, Li E, Fidler IJ, Dinney CP.
    Clin Cancer Res; 1999 Apr 15; 5(4):783-9. PubMed ID: 10213213
    [Abstract] [Full Text] [Related]

  • 38. [Lymphangiogenesis and biological activity ov vascular endothelial growth factor-C].
    Mandriota SJ, Pepper MS.
    J Soc Biol; 1999 Apr 15; 193(2):159-63. PubMed ID: 10451350
    [Abstract] [Full Text] [Related]

  • 39. Inhibition of vascular endothelial growth factor (VEGF) as a novel approach for cancer therapy.
    Wood JM.
    Medicina (B Aires); 2000 Apr 15; 60 Suppl 2():41-7. PubMed ID: 11188930
    [Abstract] [Full Text] [Related]

  • 40. Vascular endothelial growth factor/KDR activated microvessel density versus CD31 standard microvessel density in non-small cell lung cancer.
    Koukourakis MI, Giatromanolaki A, Thorpe PE, Brekken RA, Sivridis E, Kakolyris S, Georgoulias V, Gatter KC, Harris AL.
    Cancer Res; 2000 Jun 01; 60(11):3088-95. PubMed ID: 10850461
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 28.